Apoptosis, or programmed cell death, plays a critical role in Alzheimer's disease (AD) pathogenesis. In AD, neurons undergo apoptosis due to various factors, including accumulation of beta-amyloid plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein. These abnormalities disrupt cellular function and lead to neuronal death, contributing to the progressive cognitive decline observed in AD patients. Understanding the mechanisms of apoptosis in AD is crucial for developing therapeutic strategies aimed at preserving neuronal integrity and slowing disease progression. Research focuses on interventions that can modulate apoptotic pathways to protect neurons from degeneration, offering hope for future treatments that may alleviate symptoms and improve quality of life for those affected by this devastating neurodegenerative disorder.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China